Literature DB >> 17659187

Subcortical ischemic vascular dementia.

Helena C Chui1.   

Abstract

Subcortical ischemic vascular dementia (SIVD) has been proposed as a subtype of vascular cognitive impairment. MRI often discloses "silent" hyperintensities in 20% to 40% of community-dwelling elderly. Efforts to relate MRI-measured lacunes and white matter changes to cognitive impairment have not been straightforward. The possibility that Alzheimer's disease pathology contributes to cognitive impairment increases with age. A rare disorder known as cerebral autosomal dominant arteriopathy with subcortical infarctions and leukoencephalopathy (CADASIL) provides an opportunity to study SIVD in the absence of Alzheimer's disease. Lacunes and deep white matter changes are associated with dysexecutive syndrome. Hypertension, the leading risk factor for sporadic SIVD, is treatable. High priority must be given to reducing vascular risk profiles.

Entities:  

Mesh:

Year:  2007        PMID: 17659187      PMCID: PMC2084201          DOI: 10.1016/j.ncl.2007.04.003

Source DB:  PubMed          Journal:  Neurol Clin        ISSN: 0733-8619            Impact factor:   3.806


  65 in total

1.  Thalamic infarcts: clinical syndromes, etiology, and prognosis.

Authors:  J Bogousslavsky; F Regli; A Uske
Journal:  Neurology       Date:  1988-06       Impact factor: 9.910

Review 2.  Parallel organization of functionally segregated circuits linking basal ganglia and cortex.

Authors:  G E Alexander; M R DeLong; P L Strick
Journal:  Annu Rev Neurosci       Date:  1986       Impact factor: 12.449

3.  Why do frontal lobe symptoms predominate in vascular dementia with lacunes?

Authors:  N Ishii; Y Nishihara; T Imamura
Journal:  Neurology       Date:  1986-03       Impact factor: 9.910

4.  Hippocampal and cortical atrophy predict dementia in subcortical ischemic vascular disease.

Authors:  G Fein; V Di Sclafani; J Tanabe; V Cardenas; M W Weiner; W J Jagust; B R Reed; D Norman; N Schuff; L Kusdra; T Greenfield; H Chui
Journal:  Neurology       Date:  2000-12-12       Impact factor: 9.910

Review 5.  Research criteria for subcortical vascular dementia in clinical trials.

Authors:  T Erkinjuntti; D Inzitari; L Pantoni; A Wallin; P Scheltens; K Rockwood; G C Roman; H Chui; D W Desmond
Journal:  J Neural Transm Suppl       Date:  2000

6.  Senile dementia of the Binswanger type. A vascular form of dementia in the elderly.

Authors:  G C Román
Journal:  JAMA       Date:  1987-10-02       Impact factor: 56.272

7.  Pathogenesis of Binswanger chronic progressive subcortical encephalopathy.

Authors:  J De Reuck; L Crevits; W De Coster; G Sieben; H vander Eecken
Journal:  Neurology       Date:  1980-09       Impact factor: 9.910

8.  Dementia following strokes in the mesencephalon and diencephalon.

Authors:  D I Katz; M P Alexander; A M Mandell
Journal:  Arch Neurol       Date:  1987-11

9.  Nonhaemorrhagic thalamic infarction. Clinical, neuropsychological and electrophysiological findings in four anatomical groups defined by computerized tomography.

Authors:  N R Graff-Radford; H Damasio; T Yamada; P J Eslinger; A R Damasio
Journal:  Brain       Date:  1985-06       Impact factor: 13.501

10.  The neuropsychology of paramedian thalamic infarction.

Authors:  D T Stuss; A Guberman; R Nelson; S Larochelle
Journal:  Brain Cogn       Date:  1988-12       Impact factor: 2.310

View more
  39 in total

1.  Cerebrovascular disease, β-amyloid, and cognition in aging.

Authors:  Natalie L Marchant; Bruce R Reed; Charles S DeCarli; Cindee M Madison; Michael W Weiner; Helena C Chui; William J Jagust
Journal:  Neurobiol Aging       Date:  2011-11-01       Impact factor: 4.673

2.  Leukoaraiosis severity and list-learning in dementia.

Authors:  Catherine C Price; Kelly Davis Garrett; Angela L Jefferson; Stephanie Cosentino; Jared J Tanner; Dana L Penney; Rodney Swenson; Tania Giovannetti; Brianne Magouirk Bettcher; David J Libon
Journal:  Clin Neuropsychol       Date:  2009-08       Impact factor: 3.535

Review 3.  Hypertension and cerebrovascular dysfunction.

Authors:  Costantino Iadecola; Robin L Davisson
Journal:  Cell Metab       Date:  2008-06       Impact factor: 27.287

4.  Cerebral atherosclerosis is associated with cystic infarcts and microinfarcts but not Alzheimer pathologic changes.

Authors:  Ling Zheng; Harry V Vinters; Wendy J Mack; Chris Zarow; William G Ellis; Helena C Chui
Journal:  Stroke       Date:  2013-07-25       Impact factor: 7.914

Review 5.  The impact of vascular burden on late-life depression.

Authors:  Micaela Santos; Enikö Kövari; Patrick R Hof; Gabriel Gold; Constantin Bouras; Panteleimon Giannakopoulos
Journal:  Brain Res Rev       Date:  2009-09-08

6.  Hypertension as a risk factor for developing depressive symptoms among community-dwelling elders.

Authors:  Luis García-Fabela; Efrén Melano-Carranza; Sara Aguilar-Navarro; Juan Miguel Antonio García-Lara; Luis Miguel Gutiérrez-Robledo; José Alberto Avila-Funes
Journal:  Rev Invest Clin       Date:  2009 Jul-Aug       Impact factor: 1.451

Review 7.  The neuropathology and cerebrovascular mechanisms of dementia.

Authors:  Limor Raz; Janice Knoefel; Kiran Bhaskar
Journal:  J Cereb Blood Flow Metab       Date:  2016-01       Impact factor: 6.200

8.  Neuropsychological Profiles Differentiate Alzheimer Disease from Subcortical Ischemic Vascular Dementia in an Autopsy-Defined Cohort.

Authors:  Liliana Ramirez-Gomez; Ling Zheng; Bruce Reed; Joel Kramer; Dan Mungas; Chris Zarow; Harry Vinters; John M Ringman; Helena Chui
Journal:  Dement Geriatr Cogn Disord       Date:  2017-06-09       Impact factor: 2.959

9.  Stuttering Following Acquired Brain Damage: A Review of the Literature.

Authors:  Kristine Lundgren; Nancy Helm-Estabrooks; Reva Klein
Journal:  J Neurolinguistics       Date:  2010-09-01       Impact factor: 1.710

Review 10.  Advances in chronic cerebral circulation insufficiency.

Authors:  Da Zhou; Ran Meng; Si-Jie Li; Jing-Yuan Ya; Jia-Yue Ding; Shu-Ling Shang; Yu-Chuan Ding; Xun-Ming Ji
Journal:  CNS Neurosci Ther       Date:  2017-11-15       Impact factor: 5.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.